<?xml version='1.0' encoding='utf-8'?>
<document id="21296105"><sentence text="Fentanyl-trazodone-paracetamol triple drug combination: multimodal analgesia in a mouse model of visceral pain."><entity charOffset="19-30" id="DDI-PubMed.21296105.s1.e0" text="paracetamol" /></sentence><sentence text="Multimodal or balanced analgesia is commonly used in the management of acute and chronic pain in humans, in order to achieve the best analgesic/safety profile" /><sentence text=" Here, by using a model of visceral acute tonic pain, the acetic acid-induced writhing test of mice, we show a synergistic interaction between fentanyl, trazodone and paracetamol on the inhibition of nociception"><entity charOffset="58-69" id="DDI-PubMed.21296105.s3.e0" text="acetic acid" /><entity charOffset="143-151" id="DDI-PubMed.21296105.s3.e1" text="fentanyl" /><entity charOffset="153-162" id="DDI-PubMed.21296105.s3.e2" text="trazodone" /><entity charOffset="167-178" id="DDI-PubMed.21296105.s3.e3" text="paracetamol" /><pair ddi="false" e1="DDI-PubMed.21296105.s3.e0" e2="DDI-PubMed.21296105.s3.e0" /><pair ddi="false" e1="DDI-PubMed.21296105.s3.e0" e2="DDI-PubMed.21296105.s3.e1" /><pair ddi="false" e1="DDI-PubMed.21296105.s3.e0" e2="DDI-PubMed.21296105.s3.e2" /><pair ddi="false" e1="DDI-PubMed.21296105.s3.e0" e2="DDI-PubMed.21296105.s3.e3" /><pair ddi="false" e1="DDI-PubMed.21296105.s3.e1" e2="DDI-PubMed.21296105.s3.e1" /><pair ddi="false" e1="DDI-PubMed.21296105.s3.e1" e2="DDI-PubMed.21296105.s3.e2" /><pair ddi="false" e1="DDI-PubMed.21296105.s3.e1" e2="DDI-PubMed.21296105.s3.e3" /><pair ddi="false" e1="DDI-PubMed.21296105.s3.e2" e2="DDI-PubMed.21296105.s3.e2" /><pair ddi="false" e1="DDI-PubMed.21296105.s3.e2" e2="DDI-PubMed.21296105.s3.e3" /></sentence><sentence text=" First of all, once assessed that all drugs induced dose-related antinociceptive effects, they were mixed in fixed ratio (1:1) combinations and a synergistic drug-drug interaction was obtained in all circumstances" /><sentence text=" Thereafter, we assayed the effects of the triple combination of fentanyl-trazodone-paracetamol and it was demonstrated that they displayed a potent synergistic interaction on the inhibition of acetic acid-mediated nociception"><entity charOffset="84-95" id="DDI-PubMed.21296105.s5.e0" text="paracetamol" /><entity charOffset="194-205" id="DDI-PubMed.21296105.s5.e1" text="acetic acid" /><pair ddi="false" e1="DDI-PubMed.21296105.s5.e0" e2="DDI-PubMed.21296105.s5.e0" /><pair ddi="false" e1="DDI-PubMed.21296105.s5.e0" e2="DDI-PubMed.21296105.s5.e1" /></sentence><sentence text=" Interestingly, drug dosage reduction permitted to reduce the incidence of possible adverse effects, namely exploratory activity and motor coordination, thus it was demonstrated that it improved the benefit/risk profile of such treatment" /><sentence text=" Afterwards, we attempted to elucidate the mechanism of action of such interaction, by means of the non-selective opioid receptor antagonist naloxone"><entity charOffset="114-120" id="DDI-PubMed.21296105.s7.e0" text="opioid" /><entity charOffset="141-149" id="DDI-PubMed.21296105.s7.e1" text="naloxone" /><pair ddi="false" e1="DDI-PubMed.21296105.s7.e0" e2="DDI-PubMed.21296105.s7.e0" /><pair ddi="false" e1="DDI-PubMed.21296105.s7.e0" e2="DDI-PubMed.21296105.s7.e1" /></sentence><sentence text=" Interestingly, naloxone completely antagonized the antinociceptive effects of fentanyl, and it also partially reversed paracetamol and trazodone mediated analgesia"><entity charOffset="16-24" id="DDI-PubMed.21296105.s8.e0" text="naloxone" /><entity charOffset="79-87" id="DDI-PubMed.21296105.s8.e1" text="fentanyl" /><entity charOffset="120-131" id="DDI-PubMed.21296105.s8.e2" text="paracetamol" /><entity charOffset="136-145" id="DDI-PubMed.21296105.s8.e3" text="trazodone" /><pair ddi="false" e1="DDI-PubMed.21296105.s8.e0" e2="DDI-PubMed.21296105.s8.e0" /><pair ddi="false" e1="DDI-PubMed.21296105.s8.e0" e2="DDI-PubMed.21296105.s8.e1" /><pair ddi="false" e1="DDI-PubMed.21296105.s8.e0" e2="DDI-PubMed.21296105.s8.e2" /><pair ddi="false" e1="DDI-PubMed.21296105.s8.e0" e2="DDI-PubMed.21296105.s8.e3" /><pair ddi="false" e1="DDI-PubMed.21296105.s8.e1" e2="DDI-PubMed.21296105.s8.e1" /><pair ddi="false" e1="DDI-PubMed.21296105.s8.e1" e2="DDI-PubMed.21296105.s8.e2" /><pair ddi="false" e1="DDI-PubMed.21296105.s8.e1" e2="DDI-PubMed.21296105.s8.e3" /><pair ddi="false" e1="DDI-PubMed.21296105.s8.e2" e2="DDI-PubMed.21296105.s8.e2" /><pair ddi="false" e1="DDI-PubMed.21296105.s8.e2" e2="DDI-PubMed.21296105.s8.e3" /></sentence><sentence text=" Furthermore, when naloxone was co-administered with the triple-drug treatment it blocked the previously observed enhanced antinociceptive effects of the combination"><entity charOffset="19-27" id="DDI-PubMed.21296105.s9.e0" text="naloxone" /></sentence><sentence text=" Thus, these results indicated that the endogenous opioid system played a main role in the present drug-drug interaction" /><sentence text=" Overall, the triple combination of fentanyl-trazodone-paracetamol induced a potent synergistic antinociceptive effect, which could be of interest for optimal multimodal clinical analgesia"><entity charOffset="36-54" id="DDI-PubMed.21296105.s11.e0" text="fentanyl-trazodone" /><entity charOffset="55-66" id="DDI-PubMed.21296105.s11.e1" text="paracetamol" /><pair ddi="false" e1="DDI-PubMed.21296105.s11.e0" e2="DDI-PubMed.21296105.s11.e0" /><pair ddi="false" e1="DDI-PubMed.21296105.s11.e0" e2="DDI-PubMed.21296105.s11.e1" /></sentence><sentence text="" /></document>